Correlation Between Krebs Biochemicals and Sandhar Technologies

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Krebs Biochemicals and Sandhar Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Krebs Biochemicals and Sandhar Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Krebs Biochemicals and and Sandhar Technologies Limited, you can compare the effects of market volatilities on Krebs Biochemicals and Sandhar Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Krebs Biochemicals with a short position of Sandhar Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Krebs Biochemicals and Sandhar Technologies.

Diversification Opportunities for Krebs Biochemicals and Sandhar Technologies

0.46
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Krebs and Sandhar is 0.46. Overlapping area represents the amount of risk that can be diversified away by holding Krebs Biochemicals and and Sandhar Technologies Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sandhar Technologies and Krebs Biochemicals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Krebs Biochemicals and are associated (or correlated) with Sandhar Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sandhar Technologies has no effect on the direction of Krebs Biochemicals i.e., Krebs Biochemicals and Sandhar Technologies go up and down completely randomly.

Pair Corralation between Krebs Biochemicals and Sandhar Technologies

Assuming the 90 days trading horizon Krebs Biochemicals is expected to generate 2.29 times less return on investment than Sandhar Technologies. In addition to that, Krebs Biochemicals is 1.48 times more volatile than Sandhar Technologies Limited. It trades about 0.02 of its total potential returns per unit of risk. Sandhar Technologies Limited is currently generating about 0.07 per unit of volatility. If you would invest  22,305  in Sandhar Technologies Limited on October 29, 2024 and sell it today you would earn a total of  22,020  from holding Sandhar Technologies Limited or generate 98.72% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy99.59%
ValuesDaily Returns

Krebs Biochemicals and  vs.  Sandhar Technologies Limited

 Performance 
       Timeline  
Krebs Biochemicals and 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Krebs Biochemicals and are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite fairly weak fundamental drivers, Krebs Biochemicals demonstrated solid returns over the last few months and may actually be approaching a breakup point.
Sandhar Technologies 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Sandhar Technologies Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Even with latest inconsistent performance, the Stock's technical indicators remain invariable and the latest agitation on Wall Street may also be a sign of long-running gains for the enterprise retail investors.

Krebs Biochemicals and Sandhar Technologies Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Krebs Biochemicals and Sandhar Technologies

The main advantage of trading using opposite Krebs Biochemicals and Sandhar Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Krebs Biochemicals position performs unexpectedly, Sandhar Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sandhar Technologies will offset losses from the drop in Sandhar Technologies' long position.
The idea behind Krebs Biochemicals and and Sandhar Technologies Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.

Other Complementary Tools

Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios